Adage Capital Partners Gp, L.L.C. Pfizer Inc Transaction History

Adage Capital Partners Gp, L.L.C.

$51 Billion
Q1 2024

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Pfizer Inc stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 1,599,522 shares of PFE stock, worth $44.8 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

1,599,522

Previous 4,003,189 60.04%

Holding current value

$44.8 Million

Previous $115 Million 61.49%

% of portfolio

0.09%

Previous 0.25%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $62.2 Million - $71.5 Million	-2,403,667 Reduced 60.04%	1,599,522 $44.4 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $19.2 Million - $25 Million	-736,483 Reduced 15.54%	4,003,189 $115 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $43.8 Million - $51.2 Million	1,365,295 Added 40.46%	4,739,672 $157 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $599,266 - $693,337	16,591 Added 0.49%	3,374,377 $124 Million
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $45.6 Million - $59.4 Million	-1,157,391 Reduced 25.63%	3,357,786 $137 Million

Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $12.3 Million - $16 Million	-294,164 Reduced 6.12%	4,515,177 $231 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $27.6 Million - $33.7 Million	-630,260 Reduced 11.59%	4,809,341 $210 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $54.3 Million - $64.4 Million	-1,168,000 Reduced 17.68%	5,439,601 $285 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $37.8 Million - $46.8 Million	-825,900 Reduced 11.11%	6,607,601 $342 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $69.2 Million - $103 Million	1,674,400 Added 29.07%	7,433,501 $439 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $226 Million - $290 Million	5,759,101 New	5,759,101 $248 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $15.4 Million - $17.4 Million	-427,801 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $14.3 Million - $16.2 Million	427,801 New	427,801 $15.5 Million
Q3 2020 Nov 16, 2020	SELL	$31.75 - $37.25 $59.2 Million - $69.4 Million	-1,863,201 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $141 Million - $171 Million	-4,677,680 Reduced 71.51%	1,863,201 $60.9 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $261,920 - $374,227	9,690 Added 0.15%	6,540,881 $213 Million
Q4 2019 Feb 14, 2020	SELL	$32.92 - $37.36 $200,812 - $227,896	-6,100 Reduced 0.09%	6,531,191 $256 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $1.04 Million - $1.35 Million	-32,100 Reduced 0.49%	6,537,291 $235 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $39.6 Million - $44.5 Million	-1,071,767 Reduced 14.03%	6,569,391 $285 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $10.3 Million - $11.3 Million	-274,400 Reduced 3.47%	7,641,158 $325 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $19.2 Million - $21.9 Million	499,300 Added 6.73%	7,915,558 $346 Million
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $11.8 Million - $14.4 Million	343,710 Added 4.86%	7,416,258 $327 Million
Q2 2018 Aug 14, 2018	BUY	$32.98 - $35.16 $13.2 Million - $14.1 Million	401,450 Added 6.02%	7,072,548 $257 Million
Q1 2018 May 15, 2018	SELL	$31.91 - $37.02 $4.88 Million - $5.66 Million	-153,000 Reduced 2.24%	6,671,098 $237 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $4.4 Million - $4.67 Million	-132,200 Reduced 1.9%	6,824,098 $247 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $216 Million - $238 Million	6,956,298	6,956,298 $248 Million

Others Institutions Holding PFE

# of Institutions

3,158

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Pfizer Inc Transaction History